Brain NAD in Alzheimer's Disease

Part of paid clinical trials in Boca Raton, Florida.

Sponsor
Florida Atlantic University
Study ID
NCT07127510
Status
Recruiting
Apply to this trial

Conditions

  • Alzheimer Disease (AD)

Eligibility Criteria

Sex
ALL
Age
65 Years - 80 Years
Healthy Volunteers
Accepted

Study Details

The goal of this observational study is to learn about the levels of nicotinamide adenine dinucleotide (NAD) in the brains of people with Alzheimer's disease. The study aims to determine if brain NAD levels are lower in people with Alzheimer's disease compared with people of the same age group who do not have Alzheimer's disease. Participants with or without Alzheimer's disease will have a brain imaging session where NAD will be measured using magnetic resonance spectroscopy (MRS). Eight months later, they will have a second, similar, brain imaging session.

Key Dates

Start date
Mar 18, 2026
Status verified
Mar 2026
Primary completion
Apr 1, 2027
Completion
Jun 1, 2027

Study Design

Enrollment
20 participants (estimated)

Arms

  • Arm: Alzheimer's disease group
    People diagnosed with Alzheimer's disease
  • Arm: Control group
    People without Alzheimer's disease

Primary Outcome Measure

Brain NAD [ Time Frame: At enrollment and 8 months after enrollment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
FAU Clinical Research UnitBoca RatonFlorida33431
Judyta Kociolek
[email protected]
5612974963

Find similar trials in Boca Raton, FL

By research site
FAU Clinical Research Unit· Boca Raton, FL

Related Studies